Mayo Clinic COVID-19 Task Force

Organization
Contact Email
Abstract

The Mayo Clinic COVID-19 Task Force was established to enable, coordinate, and catalog research studies and practice demands of COVID-19. The task force manages research across the whole translational spectrum, aligning competing and duplicative studies to steward research resources and coordinates Institutional Review Board, Center for Clinical and Translational Science (CCaTS) Office of Clinical Trials, Department of Laboratory Medicine and Pathology, Biosafety team, and pharmacy research services to expedite execution of studies. The task force works to ensure the safety and well-being of patients, staff and subjects. The task force has approved 417 projects to date, including the convalescent plasma emergency access program.

Authors
Andrew
Badley
Chair, Molecular Medicine
Hongfang
Liu
Jennifer
Weis
Research Administrator
Laura
Meiners
Director of Research Operations
Claudia
Lucchinetti
Physician Scientist; Professor of Neuroscience; Department Chair Neurology